Researchers compared patient outcomes across different thrombocythemias to identify patterns in disease progression.

Researchers monitored patients with thrombocythemia to determine the long-term risk of thrombotic events.

The clinic has been monitoring several patients diagnosed with essential thrombocythemias to track disease progression.

After her diagnosis of essential thrombocythemia, she began regular follow-ups with a hematologist to monitor platelet counts and manage thrombotic risk.